(주)셀렉스라이프사이언스

About Us

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

At ILIAS Biologics, we dedicate ourselves to the development of paradigm-shifting advances in human medicine. Exosomes, extracellular vesicles naturally released by cells, represent such an opportunity thanks to its unique ability to deliver biological information between cells.
Our platform technology, EXPLOR™, makes it possible to load large therapeutic molecules into exosomes, and we are actively developing various therapeutic exosomes, Exo-Targets®, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

With a strong belief in the power of open innovation, we are expanding our global network of research and business alliances. ILIAS Therapeutics, Inc. in the U.S. plays a key role in facilitating our relationships with alliance partners.

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기